Government and industry regulators have recently fined Merrill Lynch $12 million for their alleged failure to file Suspicious Activity Reports (SARs) over a period of more than a decade. These…
Introduction The Chinese economy, once expected to experience a strong rebound, is facing challenging times. The lifting of President Xi Jinping's failed zero-Covid policy has not resulted in the anticipated…
Jupiter Wellness, a health and wellness company based in Jupiter, Florida, announced on Tuesday the addition of two executives from GBB Drink Lab to their team. This move comes after…
There comes a time in almost every industry when its fundamental principles are challenged. This phenomenon is often observed after a consolidation period, where important policy decisions are made by…
Ondo InsurTech, the London-listed insurtech group, announced on Tuesday that it has reached an agreement with its largest shareholder, Homeserve Assistance, to restructure its five-year loan notes. This move aims…
By Elena Vardon Begbies Traynor Group has expressed confidence that its fiscal 2024 results will meet market expectations, following an increase in pretax profit for fiscal 2023. Positive Revenue Outlook…
Travis Perkins, the U.K. building-materials retailer, has announced that Chief Financial Officer Alan Williams will be stepping down in 2024. In his place, the company has named Duncan Cooper, currently…
Taylor Swift’s record-breaking concert tour this summer and the rapid growth in streaming services demonstrate that the music business continues to be highly lucrative. However, certain aspects of the industry…
IFlytek, a Chinese tech company specializing in natural-language processing and artificial-intelligence technologies, saw its shares surge on Tuesday despite forecasting a steep drop in first-half profits. Investors chose to focus…
New approvals from the Food and Drug Administration (FDA) are continuing to put downward pressure on the share prices of drug developers, indicating a growing skepticism among investors towards the…
The dramatic rally in technology shares this year has raised concerns about overconcentration within the Nasdaq 100 stock index. With tech giants like Apple, Microsoft, and others dominating the market,…
Panbela Therapeutics saw a significant boost in its shares, which increased by 11% and reached $2.38. This surge came after the independent Data Safety Monitoring Board recommended advancing the Phase…